bioMerieux

Activities: Regulatory Analysis

Trending Articles

  1. Novo Nordisk invests DKK 8.5bn into new Danish modular production site This is the first time this century that Novo Nordisk has invested into its Danish production capabilities, with the site being capable of manufacturing product types within...
  2. Supporting accurate high-pressure flow measurement with Titan's Oval Gear liquid flow meters The Oval Gear liquid flow meter is built to perform in extreme conditions, and can be customised to a range of industries, including aerospace, mining, marine, automotive and...
  3. Bayer's acoramidis recommended for approval by the EMA's CHMP for cardiomyopathy The orally administered transthyretin (TTR) stabiliser is suitable for patients with transthyretin amyloid cardiomyopathy, demonstrating at least a 90% TTR stabilisation...
  4. Nipro and Owen Mumford partner to distribute drug delivery device, UniSafe The medical device is a patient-centric method for the delivery of injectable medicines, and is designed to enhance compliance
  5. BioMarin Pharmaceutical expands Cork targeted therapy manufacturing facility with new lab The Irish facility is responsible for the development and commercialisation of therapies that address genetic conditions, and this expansion will allow the company to enhance...

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Regulatory

bioMérieux and JMI Laboratories partner to fight antimicrobial resistance

JMI Laboratories is a recent member of the Element Group, a leading global Testing, Inspection and Certification (TIC) company, through acquisition in November 2021
Drug Delivery

InDevR raises $9m in series B financing

ioMérieux will also become the exclusive distributor of the VaxArray portfolio in Europe
Regulatory

bioMérieux receives FDA clearance for mass spectrometry ID system

With 1.3 million deaths worldwide annually, antimicrobial resistance (AMR) is a global health priority
Manufacturing

Recombinant Factor C assay to aid demand for LAL endotoxin testing

Kevin Williams from bioMerieux discusses the recombinant Factor C assay that has been developed to help alleviate the pressures of a growing demand for the Limulus amoebocyte lysate assay
Analysis

bioMérieux launches automated diagnostic solution for microbial detection

EviSight Compact provides reliable results for increased product safety and reduces costs for pharmaceutical companies
Finance

BioMérieux acquires Hyglos for a total consideration of €24m

Expands its offering for the detection of endotoxins in pharmaceutical products
Analysis

Revolutionised and Robust: Environmental Identification Webinar - mid-October

Environmental identification, including moulds, by MALDI-TOF Mass Spectrometry
Subscribe now